Critical physicochemical and biological attributes of nanoemulsions for pulmonary delivery of rifampicin by nebulization technique in tuberculosis treatment

References

• Aam BB, Heggset EB, Norberg AL. et al. (2010). Production of chitooligosaccharides and their potential applications in medicine. Mar Drugs 8:1482–517.
   PubMed Web of Science ®Google Scholar
• Ahmed M, Ramadan W, Rambhu D, et al. (2008). Potential of nanoemulsions for intravenous delivery of rifampicin. Pharmazie 63:806–11.
   PubMed Web of Science ®Google Scholar
• Agrawal S, Ashokraj Y, Bharatam PV, et al. (2004). Solid-state characterization of rifampicin samples and its biopharmaceutic relevance. Eur J Pharm Sci 22:127–44.
   PubMed Web of Science ®Google Scholar
• Akei H, Whitsett JA, Buroker M, et al. (2006). Surface tension influences cell shape and phagocytosis in alveolar macrophages. Am J Physiol Lung Cell Mol Physiol 291:L572–9.
   PubMed Web of Science ®Google Scholar
• Amani A, York P, Chrystyn H, et al. (2010). Evaluation of a nanoemulsion-based formulation for respiratory delivery of budesonide by nebulizers. AAPS PharmSciTech 11:1147–51.
   PubMed Web of Science ®Google Scholar
• Amidon GL, Lennernäs H, Shah VP, et al. (1995). A theoretical basis for a biopharmaceutic drug classification: the correlation of in vitro drug product dissolution and in vivo bioavailability. Pharm Res 12:413–20.
   PubMed Web of Science ®Google Scholar
• Aramaki K, Olsson U, Yamaguchi Y, Kunieda H. (1999). Effect of water-soluble alcohols on surfactant aggregation in the C12EO8 system. Langmuir 15:6226–32.
   Web of Science ®Google Scholar
• Bagchi S, Ambe G, Sathiakumar N. (2010). Determinants of poor adherence to anti-tuberculosis treatment in Mumbai, India. Int J Prev Med 1:223–32.
   PubMedGoogle Scholar
• Baldrick P. (2010). The safety of chitosan as a pharmaceutical excipient. Regul Toxicol Pharmacol 56:290–9.
   PubMed Web of Science ®Google Scholar
• Beck-Broichsitter M, Oesterheld N, Knuedeler MC, et al. (2014). On the correlation of output rate and aerodynamic characteristics in vibrating-mesh-based aqueous aerosol delivery. Int J Pharm 461:34–7.
   PubMed Web of Science ®Google Scholar
• Bernkop-Schnürch A, Dünnhaupt S. (2012). Chitosan-based drug delivery systems. Eur J Pharm Biopharm 81:463–9.
   PubMed Web of Science ®Google Scholar
• Blasi P, Schoubben A, Giovagnoli S, et al. (2009). Fighting tuberculosis: old drugs, new formulations. Expert Opin Drug Deliv 6:977–93.
   PubMed Web of Science ®Google Scholar
• Booysen LLIJ, Kalombo L, Brooks E, et al. (2013). In vivo/in vitro pharmacokinetic and pharmacodynamic study of spray-dried poly-(dl-lactic-co-glycolic) acid nanoparticles encapsulating rifampicin and isoniazid. Int J Pharm 444:10–17.
   PubMed Web of Science ®Google Scholar
• Carvalho TC, Peters JI, Williams RO. (2011). Influence of particle size on regional lung deposition-what evidence is there? Int J Pharm 406:1–10.
   PubMed Web of Science ®Google Scholar
• Chan JGY, Chan HK, Prestidge CA, et al. (2013). A novel dry powder inhalable formulation incorporating three first-line anti-tubercular antibiotics. Eur J Pharm Biopharm 83:285–92.
   PubMed Web of Science ®Google Scholar
• Chaubey P, Mishra B. (2014). Mannose-conjugated chitosan nanoparticles loaded with rifampicin for the treatment of visceral leishmaniasis. Carbohydr Polym 101:1101–8.
   PubMed Web of Science ®Google Scholar
• Chono S, Tanino T, Seki T, Morimoto K. (2008). Efficient drug targeting to rat alveolar macrophages by pulmonary administration of ciprofloxacin incorporated into mannosylated liposomes for treatment of respiratory intracellular parasitic infections. J Control Release 127:50–8.
   PubMed Web of Science ®Google Scholar
• Chuan J, Li Y, Yang L, et al. (2013). Enhanced rifampicin delivery to alveolar macrophages by solid lipid nanoparticles. J Nanopart Res 15:1–9.
   Web of Science ®Google Scholar
• Clark AR. (1995). The use of laser diffraction for the evaluation of the aerosol clouds generated by medical nebulizers. Int J Pharm 115:69–78.
   Web of Science ®Google Scholar
• Coowanitwong I, Arya V, Kulvanich P, et al. (2008). Slow release formulations of inhaled rifampin. AAPS J 10:342–8.
   PubMed Web of Science ®Google Scholar
• Doan TVP, Couet W, Olivier JC. (2011). Formulation and in vitro characterization of inhalable rifampicin-loaded PLGA microspheres for sustained lung delivery. Int J Pharm 414:112–17.
   PubMed Web of Science ®Google Scholar
• Ezekowitz RA, Sastry K, Bailly P, Warner A. (1990). Molecular characterization of the human macrophage mannose receptor: demonstration of multiple carbohydrate recognition-like domains and phagocytosis of yeasts in Cos-1 cells. J Exp Med 172:1785–94.
   PubMed Web of Science ®Google Scholar
• Farr SJ, Kellaway IW, Carman-Meakin B. (1987). Assessing the potential of aerosol-generated liposomes from pressurized pack formulations. J Control Release 5:119–27.
   Google Scholar
• Feng J, Zhao L, Yu Q. (2004). Receptor-mediated stimulatory effect of oligochitosan in macrophages. Biochem Biophys Res Commun 317:414–20.
   PubMed Web of Science ®Google Scholar
• Friedman LN, Selwyn PA. (2001). Pulmonary tuberculosis: presentation, diagnosis, and treatment. Tuberculosis: Current concepts and treatment. New York: CRC.
   Google Scholar
• Ghazanfari T, Elhissi AM, Ding Z, Taylor KM. (2007). The influence of fluid physicochemical properties on vibrating-mesh nebulization. Int J Pharm 339:103–11.
   PubMed Web of Science ®Google Scholar
• Jonsson M, Linse P. (2001). Polyelectrolyte–macroion complexation. I. Effect of linear charge density, chain length, and macroion charge. J Chem Phys 115:3406–18.
   Web of Science ®Google Scholar
• Jumaa M, Furkert FH, Müller BW. (2002). A new lipid emulsion formulation with high antimicrobial efficacy using chitosan. Eur J Pharm Biopharm 53:115–23.
   PubMed Web of Science ®Google Scholar
• Kumar PV, Asthana A, Dutta T, et al. (2006). Intracellular macrophage uptake of rifampicin loaded mannosylated dendrimers. J Drug Targeting 14:546–56.
   PubMed Web of Science ®Google Scholar
• Kurunov IUN, Ursov IG, Krasnov VA, et al. (1994). Effectiveness of liposomal antibacterial drugs in the inhalation therapy of experimental tuberculosis. Probl Tuberk 1:38–40.
   Google Scholar
• Laouini A, Andrieu V, Vecellio L, et al. (2014). Characterization of different vitamin E carriers intended for pulmonary drug delivery. Int J Pharm 471:385–90.
   PubMed Web of Science ®Google Scholar
• Law S. (2001). Stability of preservative-free tobramycin in half-normal saline. Can J Hosp Pharm 54:214–15.
   Google Scholar
• Li P, Wang Y, Zeng F, et al. (2011). Synthesis and characterization of folate conjugated chitosan and cellular uptake of its nanoparticles in HT-29 cells. Carbohydr Res 346:801–6.
   PubMed Web of Science ®Google Scholar
• Maretti E, Rossi T, Bondi M, et al. (2014). Inhaled solid lipid microparticles to target alveolar macrophages for tuberculosis. Int J Pharm 462:74–82.
   PubMed Web of Science ®Google Scholar
• Mason TG, Wilking JN, Meleson, et al. (2006). Nanoemulsions: formation, structure, and physical properties. J Phys 18:R635–66.
   Google Scholar
• Mehta SK, Kaur G, Bhasin KK. (2007). Analysis of Tween based microemulsion in the presence of TB drug rifampicin. Colloids Surf B Biointerfaces 60:95–104.
   PubMed Web of Science ®Google Scholar
• Millard JW, Alvarez-Nunez FA, Yalkowsky SH. (2002). Solubilization by cosolvents: establishing useful constants for the log–linear model. Int J Pharm 245:153–66.
   PubMed Web of Science ®Google Scholar
• Muttil P, Wang C, Hickey AJ. (2009). Inhaled drug delivery for tuberculosis therapy. Pharm Res 26:2401–16.
   PubMed Web of Science ®Google Scholar
• Nahar K, Gupta N, Gauvin R, et al. (2013). In vitro, in vivo and ex vivo models for studying particle deposition and drug absorption of inhaled pharmaceuticals. Eur J Pharm Sci 49:805–18.
   PubMed Web of Science ®Google Scholar
• Ogawa S, Decker EA, Mcclements DJ. (2003). Production and characterization of o/w emulsions containing cationic droplets stabilized by lecithin-chitosan membranes. J Agric Food Chem 51:2806–12.
   PubMed Web of Science ®Google Scholar
• O'Hara P, Hickey AJ. (2000). Respirable PLGA microspheres containing rifampicin for the treatment of tuberculosis: manufacture and characterization. Pharm Res 17:955–61.
   PubMed Web of Science ®Google Scholar
• Ohashi K, Kabasawa T, Ozeki T, et al. (2009). One-step preparation of rifampicin/poly (lactic-co-glycolic acid) nanoparticle-containing mannitol microspheres using a four-fluid nozzle spray drier for inhalation therapy of tuberculosis. J Control Release 135:19–24.
   PubMed Web of Science ®Google Scholar
• Pandey R, Khuller GK. (2005). Antitubercular inhaled therapy: opportunities, progress and challenges. J Antimicrob Chemother 55:430–5.
   PubMed Web of Science ®Google Scholar
• Park S, Kwag DS, Lee UY, et al. (2014). Highly porous poly (lactide‐co‐glycolide) microparticles for sustained tiotropium release. Polym Adv Technol 25:16–20.
   Web of Science ®Google Scholar
• Peluso G, Petillo O, Ranieri M, et al. (1994). Chitosan-mediated stimulation of macrophage function. Biomaterials 15:1215–20.
   PubMed Web of Science ®Google Scholar
• Pham DD, Fattal E, Tsapis N. (2015). Pulmonary drug delivery systems for tuberculosis treatment. Int J Pharm 478:517–29.
   PubMed Web of Science ®Google Scholar
• Puligujja P, Balkundi SS, Kendrick LM, et al. (2015). Pharmacodynamics of long-acting folic acid-receptor targeted ritonavir-boosted atazanavir nanoformulations. Biomaterials 41:141–50.
   PubMed Web of Science ®Google Scholar
• Ritger PL, Peppas NA. (1987). A simple equation for description of solute release 1. Fickian and Non-Fickian release from non-swellable devices in the form of slabs, spheres and cylinders or discs. J Control Release 5:23–36.
   Google Scholar
• Rollett A, Reiter T, Nogueira P, et al. (2012). Folic acid-functionalized human serum albumin nanocapsules for targeted drug delivery to chronically activated macrophages. Int J Pharm 427:460–6.
   PubMed Web of Science ®Google Scholar
• Saberi AH, Fang Y, Mcclements DJ. (2013). Fabrication of vitamin E-enriched nanoemulsions by spontaneous emulsification: effect of propylene glycol and ethanol on formation, stability, and properties. Food Res Int 54:812–20.
   Web of Science ®Google Scholar
• Sing G, Dwivedi H, Saraf SK, et al. (2011). Niosomal delivery of isoniazid-development and characterization. Trop J Pharm Res 10:203–10.
   Web of Science ®Google Scholar
• Son YJ, Mcconville JT. (2011). A new respirable form of rifampicin. Eur J Pharm Biopharm 78:366–76.
   PubMed Web of Science ®Google Scholar
• Song EH, Manganiello MJ, Chow YH, et al. (2012). In vivo targeting of alveolar macrophages via RAFT-based glycopolymers. Biomaterials 33:6889–97.
   PubMed Web of Science ®Google Scholar
• Sosnik A, Carcaboso ÁM, Glisoni RJ, et al. (2010). New old challenges in tuberculosis: potentially effective nanotechnologies in drug delivery. Adv Drug Deliv Rev 62:547–59.
   PubMed Web of Science ®Google Scholar
• Suarez S, O'Hara P, Kazantseva M, et al. (2001). Airways delivery of rifampicin microparticles for the treatment of tuberculosis. J Antimicrob Chemother 48:431–4.
   PubMed Web of Science ®Google Scholar
• Sung JC, Padilla DJ, Garcia-Contreras L, et al. (2009). Formulation and pharmacokinetics of self-assembled rifampicin nanoparticle systems for pulmonary delivery. Pharm Res 26:1847–55.
   PubMed Web of Science ®Google Scholar
• Tin S, Sakharkar KR, Lim CS, et al. (2009). Activity of chitosans in combination with antibiotics in Pseudomonas aeruginosa. Int J Biol Sci 5:153–60.
   PubMed Web of Science ®Google Scholar
• Tomoda K, Makino K. (2007). Effects of lung surfactants on rifampicin release rate from monodisperse rifampicin-loaded PLGA microspheres. Colloids Surf B Biointerfaces 55:115–24.
   PubMed Web of Science ®Google Scholar
• Vyas SP, Kannan ME, Jain S, et al. (2004). Design of liposomal aerosols for improved delivery of rifampicin to alveolar macrophages. Int J Pharm 269:37–49.
   PubMed Web of Science ®Google Scholar
• Vyas SP, Sakthivel T. (1994). Pressurized pack-based liposomes for pulmonary targeting of isoprenaline-development and characterization. J Microencap 11:373–80.
   PubMed Web of Science ®Google Scholar
• Wadhwa MS, Rice KG. (1995). Receptor mediated glycotargeting. J Drug Target 3:111–27.
   PubMed Web of Science ®Google Scholar
• Weers J. (2000). Dispersible powders for inhalation applications. Innov Pharm Technol 1:111–16.
   Google Scholar
• World Health Organization. (2010). Treatment of tuberculosis guidelines. 4th ed. Geneva, Switzerland: World Health Organization.
   Google Scholar
• World Health Organization. (2013). Global Tuberculosis Report 2013. Geneva, Switzerland: World Health Organization.
   Google Scholar
• Yadav AB, Sharmaa R, Muttil P, et al. (2009). Inhalable microparticles containing isoniazid and rifabutin target macrophages and stimulate the phagocyte to achieve high efficacy. Indian J Exp Biol 47:469–74.
   PubMed Web of Science ®Google Scholar
• Yaghmur A, Aserin A, Garti N. (2002). Phase behavior of microemulsions based on food-grade nonionic surfactants: effect of polyols and short-chain alcohols. Colloids Surf A 209:71–81.
   Web of Science ®Google Scholar
• Yang C, Gao S, Kjems J. (2014). Folic acid conjugated chitosan for targeted delivery of siRNA to activated macrophages in vitro and in vivo. J Mater Chem B 2:8608–15.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Huo M, Zhou J, et al. (2010). PKSolver: an add-in program for pharmacokinetic and pharmacodynamic data analysis in Microsoft Excel. Comput Methods Programs Biomed 99:306–14.
   PubMed Web of Science ®Google Scholar